COSENTYX® (secukinumab) is a prescription medicine used to treat adults with active psoriatic arthritis (PsA).

Psoriatic arthritis is a chronic, inflammatory disease of the joints and the places where tendons and ligaments connect to bone. The immune system creates inflammation that can lead to swelling, pain, fatigue and stiffness in the joints. This inflammation stops people with PsA from going about their daily lives. And since most people with PsA are between 30 - 50 years old, they’re still active and want a medication that can help them get back to as close to normal as possible. That’s what this campaign focuses on, getting back to doing the everyday things that are now a challenge.

“We know there are multiple pathways and multiple molecules involved in inflammation. IL-17A is one of these molecules that could be overproduced in plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. COSENTYX specifically targets IL-17A. Because it’s this specific pathway, that’s the reason it may be different from most other biologics.”

—Dr. Elizabeth Perkins, a Practicing Rheumatologist

Agency: FCB Health

Role: Copy Supervisor